Global Information
회사소개 | 문의 | 비교리스트

바이오마커 연구 서비스 시장 : 규모, 점유율, 전망, 시장 기회 분석(2018-2026년)

Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

리서치사 Coherent Market Insights
발행일 2019년 05월 상품 코드 865087
페이지 정보 영문
가격
US $ 4,500 ₩ 5,431,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,449,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,070,000 PPT Turned PDF (Enterprise User License)


바이오마커 연구 서비스 시장 : 규모, 점유율, 전망, 시장 기회 분석(2018-2026년) Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

정밀의료 개발에 관한 계획, 만성질환 유병률 상승 등에 의해 세계 바이오마커 연구 서비스 시장 성장이 가속화하고 있습니다.

세계의 바이오마커 연구 서비스(Biomarker Research Services) 시장을 조사했으며, 시장 개요, 서비스 유형·적응증·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 범위

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
    • 시장 개요 : 서비스 유형별
    • 시장 개요 : 적응증별
    • 시장 개요 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 분석
  • 미국 FDA 인증 바이오마커
  • 규제 시나리오
  • 미국 FDA 바이오마커 인증 프로그램
  • 주요 하이라이트
  • 합동 연구개발 및 인수합병
  • PEST 분석
  • 바이오마커 개발 및 시험 기술
  • 바이오마커 개발 파이프라인
  • 역학

제4장 세계의 바이오마커 연구 서비스 시장 : 서비스 유형별

  • 서론
  • 바이오마커 연구 서비스
  • 동반진단(CDx) 연구 서비스

제5장 세계의 바이오마커 연구 서비스 시장 : 적응증별

  • 서론
  • 종양
  • 심혈관질환
  • 감염증
  • 신경질환
  • 면역질환
  • 기타

제6장 세계의 바이오마커 연구 서비스 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 아프리카
  • 중동

제7장 경쟁 환경

  • 히트 맵 분석
  • 기업 개요
    • Noble Life Sciences, Inc.
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc.

제8장 섹션

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.06.25

Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process. The biomarker is included in the regulatory submission process for drug approval such as Investigational New Drug (IND), Biologics License Disease Indications (BLA), or New Drug Disease Indication (NDA), and are then accepted for use in that specific drug development program. Another process through which biomarkers are accepted for use in drug development is the Biomarker Qualification Program (BQP), which qualifies a biomarker for a particular context of use (COU), independent of a drug approval submission. This pathway is intended for biomarkers that are used in multiple drug development programs. Qualified biomarkers have the potential to offer valuable information that may help during drug development.

Market Dynamics

Factors such as increasing initiatives for development of precision medicine, increasing prevalence of chronic diseases, and increasing demand for development of companion diagnostics, is supporting the growth of global biomarker research services market. For instance, in 2017, National Institutes of Health launched Precision Medicine Initiative (PMI) with an investment of US$ 215 million to accelerate biomedical research and offer clinicians new tools to select therapies that can be used in a more individualized approach with patients. Moreover, potential of biomarkers in disease diagnosis, and in companion diagnostics is expected to boost global biomarker research services market growth. Organizations such as Covance, Inc., Charles River, and others are actively involved in providing biomarker research services.

Key features of the study:

  • This report provides in-depth analysis of global biomarker research services market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biomarker research services market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global biomarker research services market

Detailed Segmentation:

  • Global Biomarker Research Services Market, By Service Type:
    • Biomarker Research Services
    • CDx Research Services
  • Global Biomarker Research Services Market, By Disease Indication:
    • Oncology
    • Cardiovascular Disorder
    • Infectious Disease
    • Neurological Disorder
    • Immunological Disorder
    • Others
  • Global Biomarker Research Services Market, By Region:
    • North America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country/Region:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Noble Life Sciences, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Qualified Biomarkers By U.S. FDA
  • Regulatory Scenario
  • U.S. FDA Biomarker Qualification Program
  • Key Highlights
  • Research and Development Collaboration, Mergers, and Acquisitions
  • PEST Analysis
  • Biomarker Development and Testing Technologies
  • Biomarker Development Pipeline
  • Epidemiology

4. Global Biomarker Research Services Market, By Service Type, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Biomarker Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Companion Diagnostics (CDx) Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

5. Global Biomarker Research Services Market, By Disease Indication, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Cardiovascular Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Neurological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Immunological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

6. Global Biomarker Research Services Market, By Regions, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2026
  • North America
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Noble Life Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • REPROCELL Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Coriell Institute
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioIVT
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • ICON Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • SRI International
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Charles River Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nordic Bioscience A/S
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Proteome Sciences Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q